An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
a study on Various Advanced Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Fresno, California and other locations
- Dates
- study startedestimated completion:
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bristol-Myers Squibb
- Links
- BMS Clinical Trial Information
- FDA Safety Alerts and Recalls
- BMS Clinical Trial Patient Recruiting
- Investigator Inquiry Form
- ID
- NCT02632409
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated
- April 9, 2018